Abstract: Methods and systems are provided to deliver a neural stimulation therapy to treat apnea episodes. The methods and systems detect a respiratory pattern of a patient and identify a type associated with the respiratory pattern. A sleep stage is detected that the patient is experiencing and the method and system identify when the sleep stage warrants therapy. When the respiratory pattern corresponds to an apnea episode (AE) and the sleep stage warrants therapy, the methods and systems deliver an apnea episode terminating neuro-stimulation (AET-NS) therapy configured to terminate the AE. A type of AE therapy that is delivered may be based on the sleep stage that was detected. The methods and systems may determine whether the AET-NS therapy successfully terminated the AE, and, if not, adjust the AET-NS therapy and deliver a new AET-NS therapy.

Abstract: A method and system for characterizing an accessibility of potential left ventricular stimulus sites in connection with surgical planning for transvenous implant of a cardiac medical lead in or near a heart of a patient are provided. The method and system include obtaining image data representative of a coronary venous system for the heart of the patient to receive the lead. The method and system generate a venous map, based on the image data, representative of venous pathways for the heart of the patient. The method and system analyze the venous map to identify pathway features of interest (PFOI) within at least one select region of the venous pathways. The method and system assign scores to the PFOI based on at least one of predetermined feature-complexity relations or physician-entered complexity updates. The method and system display treatment planning information to a user based on the scores.

Abstract: Methods and systems are provided to deliver a neural stimulation therapy to treat apnea episodes. The methods and systems detect a respiratory pattern of a patient and identify a type associated with the respiratory pattern. A sleep stage is detected that the patient is experiencing and the method and system identify when the sleep stage warrants therapy. When the respiratory pattern corresponds to an apnea episode (AE) and the sleep stage warrants therapy, the methods and systems deliver an apnea episode terminating neuro-stimulation (AET-NS) therapy configured to terminate the AE. A type of AE therapy that is delivered may be based on the sleep stage that was detected. The methods and systems may determine whether the AET-NS therapy successfully terminated the AE, and, if not, adjust the AET-NS therapy and deliver a new AET-NS therapy.

Abstract: Patient tissues are imaged using, e.g., a real-time fluoroscopic imaging system, along with a lead system being implanted. Parameters representative of lead placement efficacy—such as capture thresholds, phrenic nerve stimulation thresholds, impedance values or screw-in tip mechanical resistance values—are measured at candidate implant locations. Localization parameters identifying the candidate implant locations are also measured. In one example, a display is generated substantially in real-time showing: images of the tissues of the patient and the lead system being implanted; candidate locations of the electrodes; and parameters representative of lead placement efficacy at the candidate locations. In this manner, the implanting clinician can readily view capture thresholds and other helpful parameters at various candidate locations along with actual real-time images of the tissues of the patient and the lead system being implanted.

Abstract: A foot pad device includes a foot pad, force sensors that provide force data, sensor electronics coupled to the force sensors, and a processor. The foot pad includes a ball region configured to be located under a ball of the foot of the user or a heel region configured to be located under a heel of the foot of the user. At least a portion of the force sensors is located in the ball region or the heel region of the foot pad. The sensor electronics include a flexible circuit with force sensor connection paths adapted to transmit force data from the force sensors and are configured to condition the force data to be within a conditioned force data range. The processor is configured to calculate a weight value based on the conditioned force data, a gain value, and an offset value.

Abstract: Methods and systems are provided to deliver a neural stimulation therapy to treat apnea episodes. The methods and systems detect a respiratory pattern of a patient and identify a type associated with the respiratory pattern. A sleep stage is detected that the patient is experiencing and the method and system identify when the sleep stage warrants therapy. When the respiratory pattern corresponds to an apnea episode (AE) and the sleep stage warrants therapy, the methods and systems deliver an apnea episode terminating neuro-stimulation (AET-NS) therapy configured to terminate the AE. A type of AE therapy that is delivered may be based on the sleep stage that was detected. The methods and systems may determine whether the AET-NS therapy successfully terminated the AE, and, if not, adjust the AET-NS therapy and deliver a new AET-NS therapy.

Abstract: A neurostimulation lead including an elongated lead body having a distal end and a proximal base. The lead body may have an elastic property such that the lead body is capable of flexing between different geometries. The lead may also include electrodes positioned along the lead body. The lead body may be configured to be straightened into a substantially linear geometry for delivering the lead body into an epidural space and may be biased such that the lead body is configured to have a wave-like geometry when disposed within the epidural space. The lead body may form first and second lateral segments that are joined by a corresponding linking portion when in the wave-like geometry.

Abstract: A method and system for characterizing an accessibility of potential left ventricular stimulus sites in connection with surgical planning for transvenous implant of a cardiac medical lead in or near a heart of a patient are provided. The method and system include obtaining image data representative of a coronary venous system for the heart of the patient to receive the lead. The method and system generate a venous map, based on the image data, representative of venous pathways for the heart of the patient. The method and system analyze the venous map to identify pathway features of interest (PFOI) within at least one select region of the venous pathways. The method and system assign scores to the PFOI based on at least one of predetermined feature-complexity relations or physician-entered complexity updates. The method and system display treatment planning information to a user based on the scores.

Abstract: A method and system are provided for determining fluid status with a central venous system of a heart. Dynamic impedance (DI) data and static impedance (SI) data are collected over multiple cardiac cycles (CC) for a persistent time period of interest (POI). The DI and SI data are collected along a central venous (CV) vector that extends through a superior vena cava (SVC). The DI and SI data are analyzed to obtain DI long-term variation (LTV) information and SI LTV information, respectively, and to detect whether the DI LTV information and the SI LTV information include decreasing persistent trends in the DI and SI data. When decreasing persistent trends are detected in the DI and SI data, an overload output is generated to indicate that the heart is experiencing a volume overload state. The DI and SI data represent a surrogate for central venous pressure.

Abstract: Patient tissues are imaged using, e.g., a real-time fluoroscopic imaging system, along with a lead system being implanted. Parameters representative of lead placement efficacy—such as capture thresholds, phrenic nerve stimulation thresholds, impedance values or screw-in tip mechanical resistance values—are measured at candidate implant locations. Localization parameters identifying the candidate implant locations are also measured. In one example, a display is generated substantially in real-time showing: images of the tissues of the patient and the lead system being implanted: candidate locations of the electrodes; and parameters representative of lead placement efficacy at the candidate locations. In this manner, the implanting clinician can readily view capture thresholds and other helpful parameters at various candidate locations along with actual real-time images of the tissues of the patient and the lead system being implanted.

Abstract: A foot pad device includes a foot pad, force sensors that provide force data, sensor electronics coupled to the force sensors, and a processor. The foot pad includes a ball region configured to be located under a ball of the foot of the user or a heel region configured to be located under a heel of the foot of the user. At least a portion of the force sensors is located in the ball region or the heel region of the foot pad. The sensor electronics include a flexible circuit with force sensor connection paths adapted to transmit force data from the force sensors and are configured to condition the force data to be within a conditioned force data range. The processor is configured to calculate a weight value based on the conditioned force data, a gain value, and an offset value.

Abstract: A foot pad device and a method of obtaining weight data from a force sensor in a foot pad worn by a user engaging in a footstep, including placing the force sensor under the ball of the foot of the user and/or the heel of the foot of the user; receiving an entered patient weight value for the user; collecting force data from the force sensor; calculating a weight value based on the collected force data and a scaling and/or offset parameter; comparing the calculated weight value to the entered patient weight value; comparing the calculated weight value to zero; adjusting the scaling and/or offset parameter; and repeating the steps periodically. The method may include comparing the collected force data to a functionality indication range, flagging the force sensor if the collected force data is outside the functionality indication range, and disregarding force data from the flagged force sensor.

Abstract: A system for providing information to a vehicle occupant includes a haptic control element which is provided in the vehicle and is configured to generate a haptic signal. An electronic control unit is operatively connected to the haptic control element and activates the haptic control element in order to indicate with a haptic signal that information is available for retrieval.

Abstract: A foot pad device and a method of obtaining weight data from a force sensor in a foot pad worn by a user engaging in a footstep, including placing the force sensor under the ball of the foot of the user and/or the heel of the foot of the user; receiving an entered patient weight value for the user; collecting force data from the force sensor; calculating a weight value based on the collected force data and a scaling and/or offset parameter; comparing the calculated weight value to the entered patient weight value; comparing the calculated weight value to zero; adjusting the scaling and/or offset parameter; and repeating the steps periodically. The method may include comparing the collected force data to a functionality indication range, flagging the force sensor if the collected force data is outside the functionality indication range, and disregarding force data from the flagged force sensor.

Abstract: A system for providing information to a vehicle occupant includes a haptic control element which is provided in the vehicle and is configured to generate a haptic signal. An electronic control unit is operatively connected to the haptic control element and activates the haptic control element in order to indicate with a haptic signal that information is available for retrieval.